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We report on infection patterns in 5 households (78 participants) delineating the natural history of human rhinovirus (HRV). 
Nasopharyngeal collections were obtained every 3–4 days irrespective of symptoms, over a 6-month period, with molecular screen-
ing for HRV and typing by sequencing VP4/VP2 junction. Overall, 311/3468 (8.9%) collections were HRV positive: 256 were clas-
sified into 3 species: 104 (40.6%) HRV-A; 14 (5.5%) HRV-B, and 138 (53.9%) HRV-C. Twenty-six known HRV types (13 HRV-A, 3 
HRV-B, and 10 HRV-C) were identified (A75, C1, and C35 being most frequent). We observed continuous invasion and temporal 
clustering of HRV types in households (range 5–13 over 6 months). Intrahousehold transmission was independent of clinical status 
but influenced by age. Most (89.0%) of HRV infection episodes were limited to <14 days. Individual repeat infections were frequent 
(range 1–7 over 6 months), decreasing with age, and almost invariably heterotypic, indicative of lasting type-specific immunity and 
low cross-type protection.
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Human rhinoviruses (HRV) are frequently detected in both chil-
dren and adults with acute respiratory infections [1, 2], common 
colds [3], bronchiolitis and pneumonia [4], acute otitis media, 
and acute wheezing [5]. Although usually mild and self-limiting, 
HRV infections may exacerbate asthma [6] or other preexisting 
respiratory illnesses [7], and are sometimes associated with hos-
pitalization with lower respiratory tract infection [8]. In sub-Sa-
haran Africa, HRV prevalence in children <5 years presenting to 
health care facilities with acute respiratory infections has ranged 
from 10% to 41% [9–11]. Asymptomatic infections are common 
and readily detected [12, 13].
HRV is a nonenveloped, single stranded, positive-sense RNA 
virus of approximately 7200 nucleotides encoding a single poly-
protein that is cleaved into 11 proteins [14]. Over 160 types, clas-
sified into 3 species (A, B, and C) based on VP1 and VP4/VP2 
genes, exist. Rhinovirus A  and B types were originally deter-
mined by neutralization assays using monospecific antisera and 
by their specific cellular receptor [15], indicating phenotypic dif-
ferences between types. Serological assays for routine diagnosis 
have largely been replaced by molecular methods targeting the 5′ 
untranslated region gene [16], which permit virus load quantifi-
cation and have previously been used to describe HRV transmis-
sion within households [13, 17–19] and child care centers [20].
HRV is spread by aerosolized droplets or surfaces contami-
nated with infected respiratory tract secretions, including direct 
human-to-human contact [21]. To date, no HRV vaccines are 
available due to antigenic heterogeneity amongst all known 
strains, lack of data identifying the most commonly circulating 
strains, or species- or type-specific virulence, and the incomplete 
understanding of antigenic differences between HRV species 
[22]. In addition, vaccine development is hindered by lack of esti-
mates of disease burden, and the common assumption that the 
infections are mild and self-limiting. Nonetheless, HRV is now 
recognized to lead to more severe disease with relevant impact on 
patient quality of life and health care-related costs [23].
Transmission is common within families, day care centers 
and schools, with studies showing several HRV types circulat-
ing in a community at the same time [24, 25]. Household and 
community-based studies provide a natural setting to track 
infections because of the high frequency of contacts and are a 
key source of information on viral transmission dynamics [26]. 
These studies provide estimates of per-infection risk of disease, 
important insights into epidemiology of respiratory infections, 
and crucial information for design of public health interven-
tions, for instance, immunization or antiviral prophylaxis [26]. 
There are no comparative household studies from Africa.
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A prospective study, with intensive sampling every 3–4 days, 
was undertaken to determine the introduction and spread of 
respiratory syncytial virus in households [27–29]. HRV and 
other respiratory viruses were detected using a multiplex real-
time polymerase chain reaction (PCR) assay [30]. Here, we use 
the PCR and sequencing data to describe occurrence and fre-
quency of symptomatic and asymptomatic HRV infections and 
reinfections, and type distribution, in 5 households in a rural 
coastal setting between December 2009 and June 2010 in Kenya.
MATERIALS AND METHODS
Study Area and Procedures
A household-based cohort study was undertaken within the 
Kilifi Health and Demographic Surveillance System (KHDSS) 
[31] for 6  months [29]. Briefly, households, eligible if they 
included an infant and at least 1 older sibling (<13 years), were 
visited twice a week by trained field assistants who collected 
nasopharyngeal swab (NPS) samples from all enrolled occu-
pants (regardless of illness) and recorded presence of respira-
tory symptoms (ie, cough, runny or blocked nose, or difficulty 
in breathing). Further details of study design and procedures 
have been previously described [28, 29]. Study protocol was 
reviewed and approved by Kenya Medical Research Institute 
Scientific and Ethical Review Unit, Kenya and Coventry 
Research Ethics Committee, UK. Individual written informed 
consent was sought from participants (≥18 years) and parents/
guardian for the children (<18 years).
Viral RNA Extraction and Amplification
Viral RNA was extracted using MagNA pure TNA high 
throughput kit (Roche). NPS samples were screened for respi-
ratory viruses using multiplex real-time reverse-transcription 
PCR (rRT-PCR) [32]. A  sample was determined positive if 
rRT-PCR cycle threshold (Ct) value was <40.0 [33]. Ct value 
was assumed to be related to viral load. VP4/VP2 sequencing 
(approximately 450 bp) was used for species and type assign-
ment. Primers amplifying approximately 549  bp of the VP4/
VP2 region (F1: 5′-CCGGCCCCTGAATGYGGCTAA-3′, F2: 
5′-ACCRACTACTTTGGGTGTCCGTG-3′; R1: 5′-TCWGG 
HARYTTCCAMCACCANCC-3′, R2: 5′- ACATRTTYTSN 
CCAAANAYDCCCAT-3′) were used in a nested 25-μL reac-
tion [34]. PCR products were purified (QIAquick PCR purifica-
tion Kit, Qiagen) and sequenced on an ABI 3130xl instrument 
(Applied Biosystems).
Phylogenetics and HRV Type Assignment
Sequence fragments (forward and reverse-complemented ori-
entations) were compared to form the best possible contig using 
Sequencher (v5.0, Gene Codes Corp), and multiple alignments 
generated using MAFFT v6.884b. Maximum likelihood trees were 
inferred in IQ-TREE [35] and branch support assessed by 1000 
bootstrap iterations [36] and SH-like approximate likelihood ratio 
test [37]. Phylogenetic analyses included VP4/VP2 sequences of 
HRV prototype strains (http://www.picornaviridae.com/sequences/
sequences.htm). Type assignment was based on sequence similar-
ity to prototype strains and pairwise genetic distance: phyloge-
netic clustering (bootstrap value >80%) and nucleotide divergence 
thresholds previously proposed by McIntyre et al (10.5%, 9.5%, and 
10.5% for HRV-A, -B, and -C, respectively) [15]. Distributions of 
pairwise distances were computed to check for clear thresholds for 
defining intertype and intratype divergence values.
Descriptive and Statistical Methods
An infection episode (either individual or household) was 
defined as the period when the same HRV type was detected 
with no more than 14 days between any 2 positive samples. This 
was supported by previous observations that rhinovirus shed-
ding lasts on average 10–14  days (illness resolves within 1–2 
weeks) [38, 39]. HRV-positive untyped samples were assumed 
to be of the same type as samples of the episode within which 
they were sandwiched. Household outbreaks were defined as 
the occurrence of more than 1 individual infection episodes 
with the same HRV type in a household and no more than 
14 days between the infection episodes. A primary or index case 
was the first person with PCR-confirmed HRV within the same 
household outbreak while secondary case(s) were the rest of the 
individual infection episodes in the same household outbreak. 
Durations of infection episodes were crudely estimated as the 
date of last positive sample minus date of first positive plus 1.   
An individual or household infection episode was defined as 
symptomatic if at least 1 sample within the episode coincided 
with presence of 1 or more respiratory symptoms.
Categorical variables were summarized as frequencies and 
their corresponding percentage distributions. Summaries 
for continuous variables were reported as mean and stan-
dard deviation (SD), and if found to have a skewed distribu-
tion were reported as median and interquartile range (IQR). 
Differences in proportions between groups were determined 
using test of proportions. Test for linear trend was used to 
investigate the trend in proportion of symptomatic cases with 
increasing age. We used logistic regression to estimate odds 
ratios (ORs) for the association between demographic and 
clinical characteristics and HRV infection status and general-
ized estimating equations with exchangeable covariance struc-
ture to account for repeated entries of the same individual. 
Kaplan-Meier functions were used to estimate survival rates 
for HRV reinfections, and log-rank test for between-group 
comparisons. Cox proportional hazard regression was used 
to obtain hazard ratios (HR) with 95% confidence intervals 
(CI) for incidence rate comparison. All statistical analyses 
were done using STATA 13.1 (Statacorp), and effects were 
considered significant for P values  ≤  .05. Epiplots depicting 
distribution of HRV types within households were plotted in 
R v3.2.1. The replication datasets, do files, and R scripts are 
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available on the Dataverse site (https://doi.org/10.7910/DVN/
NDJFNZ) [40]. The Genbank sequence accession numbers are 
KX831136–KX831389.
RESULTS
Five households, designated 5, 19, 34, 40, and 51 and consisting 
of 78 individuals in total, were selected to represent the breadth 
of household sizes in the larger cohort for detailed analysis on 
HRV infections. The minimum and maximum distance between 
the five households was 0.3 and 1.8 kilometers, respectively. The 
number of occupants (and median age in years) was 37 (11.4), 
14 (13.0), 7 (7.4), 5 (6.1), and 15 (9.2) for households 5, 19, 
34, 40, and 51, respectively. Overall, 11% of participants were 
infants (<12 months of age), 23% were 1 to ≤5 years, 17% were 6 
to ≤10 years, 17% were 11 to ≤18 years, and 32% were >18 years.
HRV Detections, Species, and Types
The total number of NPS collections from the 5 households was 
2836 and of these 313 (11%) were HRV positive. The VP4/VP2 
region (approximately 420 bases) was sequenced for 256 rRT-
PCR positive samples (82.3%); the remaining samples either 
failed to amplify with the VP4/VP2 specific primers (55) or were 
identified as non-HRV enteroviruses (2). Of the 55 untyped sam-
ples, 27 (49.1%) occurred within individual infection episodes 
and therefore were assumed to be of the same type as samples of 
the corresponding episode within which they were sandwiched. 
Overall, 104 (40.6%), 14 (5.5%) and 138 (53.9%) were HRV-A, -B, 
and -C, respectively. Additionally, 13 HRV-A, 3 HRV-B, and 10 
HRV-C defined types were identified (total of 26) and are listed 
by household in Table 1. The distribution of HRV-positive sam-
ples over the study period are shown in Figure 1 for household 
40. Similar plots for other households are in the Supplementary 
material. Figure 1 demonstrates 3 common features amongst all 
households: (1) multiple invasions, almost always of different 
types, with (2) each household outbreak lasting a short period of 
days to a few weeks, and (3) individuals were multiply infected 
with different types. Species A and C were detected in all 5 house-
holds, whereas HRV-B was detected in 4 (Table 1). C35 (n = 44) 
and C1 (n = 33) were the most commonly detected HRV-C types; 
A75 (n  =  27) was the most frequent HRV-A type; and Bpat1 
(n  =  10) the most common HRV-B type. The proportion of 
HRV-positive samples was significantly different (P value < .001) 
across age groups: <1 year (n = 81; 28.9%), 1–5 years (n = 102; 
14.7%), 6–10 years (n = 67; 13%), 11–18 years (n = 32; 7.2%), 
and >18 years (n = 31; 4.4%). Figure 2A shows the temporal dis-
tribution by species, with peak occurrence January–February for 
HRV-A, February–March for HRV-C, and no clear pattern for 
HRV-B. Supplementary Figure 1 shows the distribution of var-
ious age groups in relation to prevalence of rhinovirus species.
HRV Episode Distribution
Overall, 61/78 (78.2%) individuals experienced 1 or more 
HRV episode; typing failed in 3.  Eighteen (23.7%) had a 
single episode over the 6-month observation period, while 
43 (55.1%) had >1, up to a maximum of 7, infection epi-
sodes (Figure  2B). Cumulatively, there were 163 individual 
infection episodes (<14 days between any 2 positive samples) 
(Supplementary Figure  2), resulting in a mean of 2.24 (SD, 
1.29) episodes per person. The distribution of number of 
types per individual followed a similar pattern to the number 
of episodes (Figure  2B), with up to a maximum of 7 types, 
indicating very few instances of reinfection with the same 
type. There were 56 household infection episodes, involving 1 
or more individuals, where 23, 7, and 26 episodes were HRV-
A, -B, and -C, respectively, ranging from 8 in households 34 
and 40 to 18 in household 5 (Supplementary Figure  2). Of 
the 56 household episodes, 26 (46%) led to secondary cases 
(household outbreaks), ranging from 3 in household 51 to 
7 in households 5 and 19. The number of HRV types per 
household ranged from 5 in household 34 to 13 in house-
hold 5 (Supplementary Figure  1; Table  1). The duration 
of individual episodes ranged from 1 to 36  days (median 
1  day; Supplementary Figure  2), while duration of house-
hold episodes ranged from 1 day to 40 days (median 8 days; 
Supplementary Figure 3).
Table  1. Surveillance for Human Rhinovirus Types in 5 Households in 
Coastal Kenya 2009–2010 
HRV type HH 5 (37) HH 19 (14) HH 34 (7) HH 40 (5) HH 51 (15)
A75 + ND ND + ND
A60 + + ND ND ND
A12 + ND ND + ND
A7 + ND ND ND ND
A46 + + ND ND ND
A65 ND ND ND ND +
A62 + ND ND ND ND
A66 ND + + ND ND
A43 ND ND + ND +
A33 ND ND ND + ND
A98 ND ND ND ND +
A2 ND ND ND ND +
A101 ND ND + + ND
B3 + ND ND ND ND
B37 ND + ND ND ND
Bpat1 ND + + + ND
C1 + ND ND + +
C15 + + ND + ND
C53 + ND ND ND ND
C5 + ND + ND ND
Cpat19 + ND ND ND ND
C35 + + ND ND +
C42 ND + ND + ND
C43 ND ND ND ND +
Cpat16 ND ND ND ND +
C52 ND ND ND ND +
Total 13 8 5 8 9
Abbreviations: +, detected; HH, household; ND, not detected.
Number of occupants for each household is indicated in the first row.
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Clinical Features and Transmission
Amongst the 163 HRV individual episodes, 94 (58%) were 
asymptomatic and 69 (42%) were symptomatic: 26% had nasal 
discharge or blockage, 40.5% had cough, and 0.6% had difficulty 
breathing. The proportion of HRV-positive samples concur-
rent with presence of symptoms declined with increasing age 
(Figure 3A). The number of HRV-positive samples derived from 
asymptomatic individuals was 63.9% (200/313). Association 
between infecting rhinovirus species and presence or absence 
of respiratory symptoms, adjusted for age, was not significant 
for HRV-B (OR = 0.30; 95% CI, 0.07–1.28; P value = .104) or 
HRV-C (OR = 0.63; 95% CI, 0.36–1.08; P value = .092), using 
HRV-A as the reference group. Excluding samples positive for 
other viruses tested, specimens collected while symptomatic 
had double the odds of having a HRV infection compared to 
asymptomatic ones (OR  =  2.01; 95% CI; 1.42–2.85). Of the 
56 household episodes, 24 (42.9%) were asymptomatic and 
32 (57.1%) were symptomatic. The proportion of symptom-
atic individual episodes declined with increasing age: infants 
(66.7%), 1–5  years (48.2%), 6–10  years (38.4%), 11–18  years 
(26.3%) and >18 years (14.3%) (Χ2 = 16.7; P value < .001).
A linear regression fitted on Ct and age, and using a piecewise 
linear function for age, showed a statistically significant positive 
relationship for children <11 years (β = 0.22; 95% CI, 0.09–0.35; 
P value = .001) and a negative, not statistically significant, rela-
tionship for older children and adults ≥11 years (β = −0.044; 
95% CI, −0.1 to 0.1; P value  =  .111). This was unaffected by 
adjusting for reported symptoms: <11 years (β = 0.198; 95% CI, 
0.06–0.33; P value = .004) and ≥11 years (β = −0.047; 95% CI, 
−0.1 to 0.008; P value  =  .092). Overall, age and symptomatic 
status explained little of the variation in amount of virus shed 
in both adjusted and unadjusted models (R2 = 0.03). Slight dif-
ferences between median Ct value of symptomatic and asymp-
tomatic cases were observed across age categories (Figure 3B). 
Association between symptomatic status of the index cases and 
within household spread was not statistically significant (unad-
justed OR = 1.14; 95% CI, 0.41–3.14; P value = .801) and did not 
change after adjusting for age in years (adjusted OR = 1.02; 95% 
CI, 0.35–2.96; P value = .966). There was no statistically signifi-
cant association between viral shedding (high Ct ≤30 versus low 
Ct >30, using low as reference category) of the index case and 
that of secondary cases (with the same type) in the household 
(OR = 1.86; 95% CI, 0.67–5.17; P value = .233).
HRV Infection and Reinfection Dynamics
Overall, 11/26 types were observed in multiple households. The 
cumulative number of unique types increased rapidly initially 
then less so with time (Figure  3C). Circulation of any partic-
ular type was restricted temporally, and heterologous types, 
rather than long-term persistence of a single type, caused rhi-
novirus reinfections. The slope from linear regression analysis 
of household size (population density) and HRV type diversity 
was 0.204 (95% CI, 0.02–0.38; P value = .036). Four individuals 
had same-type reinfections Supplementary Figure 2 a 6.6 year 
old in household 5 with type A75; a 2.3 year old in household 
34 with type A43; a 4.6 year old in household 34 with type C5; 
and a 1.5  year old in household 51 with type C43. At house-
hold level, recurrence of the same type (C5 and C15 in house-
hold 5; A54, C43 and Cpat16 in household 51)  was observed 
after long (>1 month) intervening periods. Notably, there was 
a pronounced symptomatic spread of C43 in household 51 after 
a period of presumed viral absence, (6 weeks after the first 2 
asymptomatic introductions).
Children younger than 10 years were more at risk of “all HRV” 
reinfection(s) compared to older individuals. Using infants 
(0–11  months) as the reference category, older children (11–
18 years) and adults (>18 years) had a reduced risk of rhinovirus 
reinfection with HRs of 0.34 (95% CI, 0.14–0.80; P value = .013) 
and 0.17 (95% CI, 0.06–0.48; P value  =  .001), respectively 
(Figure 3D). However, compared to infants, the risk of reinfection 
was not significantly lower for children 1–5 years (HR = 0.79; 95% 
CI, 0.53–1.17; P value = .242) or for those 6–10 years (HR = 0.90; 
95% CI, 0.57–1.42; P value = .65) (Figure 3D).
0.15
2
6.1
8.9
29.5
21
-1
2-
09
28
-1
2-
09
04
-0
1-
10
11
-0
1-
10
18
-0
1-
10
25
-0
1-
10
01
-0
2-
10
08
-0
2-
10
15
-0
2-
10
22
-0
2-
10
01
-0
3-
10
08
-0
3-
10
15
-0
3-
10
22
-0
3-
10
29
-0
3-
10
05
-0
4-
10
12
-0
4-
10
19
-0
4-
10
26
-0
4-
10
03
-0
5-
10
10
-0
5-
10
Date
A
ge
 (y
ea
rs
)
A101
A12
A33
A75
Bpat1
C1
C15
C42
Untyped Non-URTI URTI
Figure 1. Distribution of human rhinovirus-positive samples collected in house-
hold 40, 1 of the 5 households in coastal Kenya, by individual and coded by type 
(color) and symptom status (filled markers, symptomatic; empty markers, asympto-
matic) at time of sample collection. As shown, age increases from the infant at the 
bottom to the oldest member of the household. The other households are shown in 
the Supplementary Figure 2. Abbreviation: URTI, upper respiratory tract infection.
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HRV Type Sequence Diversity
Strains of types A101, A75, A66, A46, C42, C1, C15, and C35, 
observed in more than 1 household, each had close sequence 
similarity (>90%) and grouped into monophyletic clusters irre-
spective of household of origin (Figure  4), suggesting a single 
virus variant circulated in the community. There were distinct 
clusters (>80% bootstrap) for HRV types A12, A43, and C1 
between households denoting diversification following trans-
mission within the community. Two HRV types were unusually 
different genetically within households: C43 in household 51 and 
C5 in household 34. Two C5 variants in household 34, detected 
>14 days apart, had 16 nucleotide and 12 amino acid differences.
Comparing the household sequences with those collected 
during the same period from Kilifi County Hospital (KCH), 
a facility that serves a larger catchment area of Kilifi County, 
HRV-A and -C viruses from household and KCH grouped in 
the same monophyletic clusters (Supplementary Figure 4), con-
firming existence of these strains within the wider Kilifi County. 
Average within-species pairwise distances for HRV-A, -B, and 
-C were 0.182, 0.101, and 0.211, respectively. Supplementary 
Table 1 shows p distances between household HRV sequences 
and their corresponding prototype strains. A66, A65, A2, 
B3, and B37 strains varied considerably from their reference 
strains: their p distances failed to conform to previously pro-
posed minimum VP4/VP2 type assignment thresholds of 
10.5% and 9.5% for HRV-A and HRV-B, respectively, despite 
strong bootstrap-supported (>90%) monophyletic clustering. 
Notwithstanding, these viruses remained classified as A66, A65, 
A2, B3, and B37.
DISCUSSION
The household setting represents an epidemiologic niche in 
which conditions facilitate respiratory disease transmission due 
to close and frequent personal contacts. Here, 5 households (78 
individuals), repeated follow-up, sampling twice weekly, and 
molecular typing allowed detection of recurrent or serial HRV 
infections from an otherwise healthy population, providing 
insights into natural infection history and transmission dynam-
ics. Diverse types were in circulation. Individuals and house-
holds were infected up to 8 and 13 times, respectively. The vast 
majority of reinfections were with heterologous types, as previ-
ously observed [12, 41]. There was little genetic diversity among 
infected individuals both within and between households. With 
time, the number of new types saturated in the households, 
although other types circulated in the wider community as 
identified by contemporaneous local hospital surveillance. This 
showcases continuous exposure to a substantial but temporally 
restricted subset of invariant types in a local household popula-
tion, where reinfection is constrained by strong homotypic but 
not heterotypic immunity. Findings from a recently published 
day care center study, using similar study design (longitudinal 
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study collecting samples from symptomatic and asymptomatic 
individuals and positives genotyped), show a high proportion 
positive in symptomless individuals, high diversity of types in 
circulation, and repeat infections are often heterotypic [20].
 These observations imply that duration of immunity to 
heterologous types is short and at most of the order of weeks, 
and that of homologous reinfection of the order of months. 
However, full duration of immunity to same-type reinfection 
could not be estimated here. Further studies of a longer period 
would shed more light on type-specific immunity. A decrease in 
reinfection rates with increasing age suggests a broader cross-
type immunity in individuals with more HRV exposure. The 
first infections observed during the study might have occurred 
rapidly due to faded immunity over the preceding year to the 
same types. In this study period, transition from A to C, with B 
being relatively rare, suggests a feasible “exclusion” mechanism.
Most infection episodes were asymptomatic and absence of 
symptoms was not associated with lower infectivity; a significant 
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proportion of asymptomatic infections contributed to transmis-
sion. This is important when estimating the rate of community 
HRV infection as it leads to underestimation if sampling is 
based on presence of symptoms. While some types were more 
common, there was no evidence of species or types associated 
with presence of symptoms. HRV infections were more com-
mon in younger relative to older individuals, with duration, 
virus shedding, reinfection rate, and proportion symptomatic, 
decreasing with increasing age, consistent with the notion that 
a longer history of exposure and disease in adults compared 
to children accounts for the diversity of clinical presentation 
and patterns of viral shedding [42, 43]. A  wide range of ages 
and substantial proportion of the household were involved in 
household outbreaks.
The observation of saturation of numbers of new types infect-
ing households with increasing time could have multiple rea-
sons including: (1) increasing type-specific immunity amongst 
the community of households, reducing the risk of continued 
spread of identified types; (2) near exhaustion of a finite set of 
types circulating in the community with which to infect house-
holds; or (3) a reflection of changes in the numbers of samples 
collected. The latter is less plausible. In spite of the significant 
linear relationship between household size (population density) 
and HRV types detected, caution should be taken in over inter-
pretation as we are dealing with only 5 data points (households).
 Rhinoviruses with p distances above minimum type assign-
ment thresholds indicate considerable nucleotide divergence 
from the closest prototype strains. Our findings extend pre-
vious observations, using serologic or genotypic analysis [19, 
44, 45], of differences in frequency of HRV occurrence. The 
strengths of our study included selection of participants and 
regularly scheduled prospective sampling independent of 
health history and irrespective of respiratory symptoms, giv-
ing an unbiased view on HRV presence in a rural community. 
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Nonetheless, the study has limitations and assumptions: (1) 
our findings were restricted to the VP4/VP2 region whereas 
full genomes would have been useful for more detailed epide-
miologic (who infects whom) and evolutionary analyses; (2) 
the small number of households studied might not be fully 
representative of the entire household cohort or generaliz-
able to other settings; (3) the short duration of follow-up lim-
its insights into duration of immunity; and (4) we assumed 
time-independent HRV exposure when estimating infec-
tion rates. These notwithstanding, the temporal patterns of 
HRV acquisition, and identification of similar HRV types in 
households and pediatric hospital admissions, suggest a gen-
eralizability of our results to a larger population. This study 
highlights the natural history of rhinovirus infections within 
a household setting, revealing patterns of viral shedding, and 
rates of infection and reinfection in relation to type diversity, 
age, and clinical symptoms.
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